Physician

Christopher Curtis Custer, M.D.

According to 2025 Medicare claims, Christopher Custer, M.D. (NPI: 1417392028) practices pain management in the Atlantic City-Hammonton, NJ market, with the plurality of this provider's patient population coming from Atlantic, NJ. This provider's primary affiliated billing organization is PREMIER BRAIN AND SPINE, LLC (NPI: 1922771377; TIN: 871737086) and primary practice location at 08221-1036.

Custer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 308 traditional Medicare patients, billed 2,969 HCPCS/CPT codes, and received $222,089 in Medicare payments. The top billing code was G0480 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 3,602 prescription claims across 336 beneficiaries totaling $388,950 in drug costs, led by Ztlido (Lidocaine). DME data shows 12 claims. Open Payments data shows 14 records totaling $232. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $126,230 and ending at $222,089. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	437	1,411	$126,230
2019	684	3,849	$318,342
2020	325	2,232	$156,565
2021	325	1,941	$166,132
2022	357	2,313	$188,592
2023	294	2,284	$175,263
2024	308	2,969	$222,089

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	203	449	$41,560
2018	724	2,697	$272,196
2019	684	4,529	$444,964
2020	421	4,670	$381,800
2021	358	3,951	$330,072
2022	404	4,109	$354,538
2023	344	3,857	$347,023
2024	336	3,602	$388,950

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	18	$1,394
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	12	$155

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	194	417	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	140	287	$96
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	242	1,179	$67
80307	Testing for presence of drug, by chemistry analyzers	207	453	$61
99484	Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional	147	241	$43

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ztlido	Lidocaine	191	6,095	$83,255
Belbuca	Buprenorphine Hcl	88	2,700	$67,422
Relistor	Methylnaltrexone Bromide	14	420	$31,806
Oxycontin	Oxycodone Hcl	63	1,807	$27,494
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	457	12,992	$13,349

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0001	Standard wheelchair	Y	N/R	12	$155

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$232	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher Curtis Custer, M.D.?

Tedicare shows public-source Medicare data for Christopher Curtis Custer, M.D. (NPI 1417392028), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Curtis Custer, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christopher Curtis Custer, M.D.?

Christopher Curtis Custer, M.D. is linked to PREMIER BRAIN AND SPINE, LLC (billing NPI 1922771377) in the available physician profile data.

Does Christopher Curtis Custer, M.D. have Open Payments data?

Christopher Curtis Custer, M.D. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.